Brivaracetam Patent Expiration
Brivaracetam is used for managing partial-onset seizures in patients with epilepsy aged 4 years and older. It was first introduced by Ucb Inc
Brivaracetam Patents
Given below is the list of patents protecting Brivaracetam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Briviact | US10729653 | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | Apr 09, 2030 | Ucb Inc |
| Briviact | US6911461 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | Feb 21, 2026 | Ucb Inc |
| Briviact | US6784197 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
| Briviact | US8492416 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
Brivaracetam's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List